Plk1 Phosphorylation of Mre11 Antagonizes the DNA Damage Response

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• The mitotic kinase Plk1 is known to regulate the DNA damage response (DDR) by acting downstream of ATM/ATR kinases.
• Understanding Plk1's role in DDR, particularly its upstream interactions, is crucial for developing targeted cancer therapies.

Purpose of the Study:

• To investigate the role of Plk1 in phosphorylating key factors upstream of ATM/ATR during the DDR.
• To elucidate the functional consequences of Plk1-mediated Mre11 phosphorylation on DNA repair and checkpoint activation.

Main Methods:

• Western blotting and mass spectrometry to identify Plk1 phosphorylation sites on Mre11.
• Cell-based assays to assess MRN complex loading, DNA damage checkpoint activation, and DNA repair kinetics.
• Xenograft tumor models to evaluate the therapeutic potential of targeting Plk1-Mre11 interactions.

Main Results:

• Plk1 directly phosphorylates Mre11 at serine 649 (S649), priming it for subsequent CK2-mediated phosphorylation at serine 688 (S688).
• Phosphorylation of Mre11 at S649/S688 inhibits the recruitment of the Mre11/Rad50/Nbs1 (MRN) complex to damaged DNA sites.
• This impaired MRN loading leads to premature termination of the DNA damage checkpoint and reduced DNA repair efficiency.

Conclusions:

• Plk1 plays a significant role in regulating the DDR by phosphorylating Mre11 upstream of ATM/ATR.
• Mre11 phosphorylation by Plk1 negatively impacts DNA repair and checkpoint signaling, potentially contributing to cancer progression.
• Tumors with phosphomimetic Mre11 show increased sensitivity to PARP inhibitors, suggesting a therapeutic strategy for patients with high Plk1 expression.